Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Innovative Treatment Approach Offers New Hope For Eczema Sufferers With Moderate To Severe Disease
Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.* It is now also approved for twice-weekly application to previously affected skin to prevent these exacerbations and prolong flare-free periods in PROTOPIC-responsive patients.ò€  Clinical studies have shown that this new approach brings significant benefits with over 40% of patients with moderate to severe eczema remaining flare-free for at least a year.1 Flares are known to place an enormous burden on patients. The International Study of Life with Atopic Eczema (ISOLATE) found that about 55% of these patients worried about the onset of their next exacerbation and that they spent on average over a third of the year (136 days) with their eczema in flare.2
generic viagra online
A New UK Survey Suggests Primary Care Clinicians Need Clearer Post-Mi Guidelines To Provide Their Patients With Optimal Care
A new survey published in the British Journal of Cardiology suggests that inconsistencies in clinical guidance for the ongoing management of post-myocardial infarction (MI) patients may contribute to significant variation in clinical practice reported by GPs and practice nurses.1a These findings indicate that, in some areas of the UK, care for post-MI patients after leaving hospital may not be optimal,1b according to authors from the Follow Your Heart group. *
News of the day
APEX Guides: Helping PBC Leaders To Become World Class Commissioners
The first three guides - Clinical Engagement, Governance and Prioritising Investment - will be launched at the Practice Based Commissioning National Forum, on 1 July. A fourth guide, on Patient and Public Engagement, will be published over the summer and a fifth, on Procurement, is already in the pipeline and expected to be published in September.
Health Insurance

California Immunization Coalition Honors Steve Baranov

The California Immunization Coalition recently bestowed the Natalie J. Smith, MD, MPH Immunization Champion Award upon Steve Baranov, vice president for community health at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and executive director of South Los Angeles Health Projects. The coalition presents the award annually to a community member who works to reduce vaccine-preventable diseases. It honored Mr. Baranov for his leadership in establishing immunization services in the Women, Infants and Children (WIC) nutrition program and for promoting the adoption of evidence-based strategies to reduce racial and ethnic disparities in immunization coverage levels. The coalition also praised him for establishing LA BioMed"s WIC program as "an immunization leader," saying its integration of immunization screening, education and referral activities into WIC operations "have led to significant improvements in immunization coverage levels in South LA." "Undoubtedly, the success and the lessons learned from LA BioMed WIC interventions have influenced the immunization efforts of the WIC programs across California," said Julia Heinzerling, president of the California Immunization Coalition. "In addition, your vision and leadership in the Immunize LA Kids and Immunize LA Families Coalitions have been instrumental in bringing diverse partners together to collaboratively implement strategies that have improved coverage levels across the lifespan for diverse and underserved communities in South LA." A long-standing board member of the California Coalition for Childhood Immunization (C3I), Mr. Baranov was instrumental in guiding the merger of the California Adult Immunization Coalition and C3I into the California Immunization Coalition. "Congratulations to Steve on this wonderful honor," said LA BioMed President and CEO Carole Wagner-Vallianos, Esq. "He is a dedicated professional who has championed programs and services that are making a difference in our community, and he serves as an outstanding example of the many contributions LA BioMed staff and researchers make every day to advancing and improving human health." Laura Mecoy Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009